97
Participants
Start Date
January 31, 2005
Primary Completion Date
July 31, 2007
Study Completion Date
July 31, 2007
levonorgestrel/EE 0.15/0.03 and EE 0.01 mg tablets
1 tablet daily
levonorgestrel/EE 0.15/0.03 mg tablets and placebo
1 tablet daily
Duramed Investigational Site, Philadelphia
Duramed Investigational Site, Norfolk
Duramed Investigational Site, Newport News
Duramed Investigational Site, Charlotte
Duramed Investigational Site, Decatur
Duramed Investigational Site, Tampa
Duramed Investigational Site, Huntsville
Duramed Investigational Site, Memphis
Duramed Investigational Site, Columbus
Duramed Investigational Site, Columbus
Duramed Investigational Site, Denver
Duramed Investigational Site, Salt Lake City
Duramed Investigational Site, Phoenix
Duramed Investigational Site, San Diego
Duramed Investigational Site, Medford
Duramed Investigational Site, Tacoma
Duramed Investigational Site, Spokane
Duramed Investigational Site, Moorestown
Lead Sponsor
Duramed Research
INDUSTRY